Cargando…

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene

Osteosarcoma (OS) is the most common primary malignant tumor of bone, showing complex chromosomal rearrangements but with few known consistent changes. Deeper biological understanding is crucial to find new therapies to improve patient survival. We have sequenced the whole exome of two primary tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barøy, Tale, Chilamakuri, Chandra S. R., Lorenz, Susanne, Sun, Jinchang, Bruland, Øyvind S., Myklebost, Ola, Meza-Zepeda, Leonardo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042545/ https://www.ncbi.nlm.nih.gov/pubmed/27685995 http://dx.doi.org/10.1371/journal.pone.0163859

Ejemplares similares

Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model
por: Barøy, Tale, et al.
Publicado: (2014)

Performance comparison of four exome capture systems for deep sequencing
por: Chilamakuri, Chandra Sekhar Reddy, et al.
Publicado: (2014)

Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
por: Namløs, Heidi M., et al.
Publicado: (2012)

Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells
por: Skårn, Magne, et al.
Publicado: (2013)

Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations
por: Lorenz, Susanne, et al.
Publicado: (2015)

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma
por: Hanes, Robert, et al.
Publicado: (2016)

Preclinical Evaluation of the Pan-FGFR Inhibitor LY2874455 in FRS2-Amplified Liposarcoma
por: Hanes, Robert, et al.
Publicado: (2019)

Global Gene Expression Profiling of Human Osteosarcomas Reveals Metastasis-Associated Chemokine Pattern
por: Namløs, Heidi M., et al.
Publicado: (2012)

Novel CHM mutations identified in Chinese families with Choroideremia
por: Cai, Xue-Bi, et al.
Publicado: (2016)

Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
por: Grad, Iwona, et al.
Publicado: (2021)

Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples
por: Kresse, Stine H., et al.
Publicado: (2018)

miRNA-133b targets FGFR1 and presents multiple tumor suppressor activities in osteosarcoma
por: Gao, Gan, et al.
Publicado: (2018)

The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype
por: Simunovic, Matthew P., et al.
Publicado: (2016)

Synonymous Variant in the CHM Gene Causes Aberrant Splicing in Choroideremia
por: da Palma, Mariana Matioli, et al.
Publicado: (2020)

Sample-Index Misassignment Impacts Tumour Exome Sequencing
por: Vodák, Daniel, et al.
Publicado: (2018)

M-CGH: Analysing microarray-based CGH experiments
por: Wang, Junbai, et al.
Publicado: (2004)

Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009
por: Berner, Kjetil, et al.
Publicado: (2015)

In silico data analyses of the hotspot mutations of CHM gene in choroideremia disease
por: Imani, Saber, et al.
Publicado: (2018)

Identification of Pathogenic Variants in the CHM Gene in Two Korean Patients With Choroideremia
por: Bae, Kunho, et al.
Publicado: (2017)

Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes
por: Lauvrak, S U, et al.
Publicado: (2013)

Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
por: Kresse, Stine H., et al.
Publicado: (2012)

Accurate 3-gene-signature for early diagnosis of liposarcoma progression
por: Serguienko, Anastassia, et al.
Publicado: (2020)

miR-486-5p expression is regulated by DNA methylation in osteosarcoma
por: Namløs, Heidi M., et al.
Publicado: (2022)

Are Michigan State University medical school (MSU-CHM) alumni more likely to practice in the region of their graduate medical education primary care program compared to non-MSU-CHM alumni?
por: Switzer, Richard, et al.
Publicado: (2018)

Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia
por: Toualbi, Lyes, et al.
Publicado: (2023)

Preclinical Evaluation of Vemurafenib as Therapy for BRAF(V600E) Mutated Sarcomas
por: Gouravan, Sarina, et al.
Publicado: (2018)

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
por: Kuijjer, Marieke L, et al.
Publicado: (2013)

mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
por: Kuijjer, Marieke L, et al.
Publicado: (2011)

Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma
por: Shao, Yang W., et al.
Publicado: (2018)

DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation
por: Kresse, Stine H., et al.
Publicado: (2010)

Novel CHM mutations in Polish patients with choroideremia – an orphan disease with close perspective of treatment
por: Skorczyk-Werner, Anna, et al.
Publicado: (2018)

Expanding the genetic spectrum of choroideremia in an Australian cohort: report of five novel CHM variants
por: McLaren, Terri L., et al.
Publicado: (2020)

Molecular Characterization of Choroideremia-Associated Deletions Reveals an Unexpected Regulation of CHM Gene Transcription
por: Fioretti, Tiziana, et al.
Publicado: (2021)

Author Response to Letter to the Editor from CHM van den Ende et al
por: Álvarez, et al.
Publicado: (2020)

excluderanges: exclusion sets for T2T-CHM13, GRCm39, and other genome assemblies
por: Ogata, Jonathan D, et al.
Publicado: (2023)

Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells
por: Henriksen, Jørn, et al.
Publicado: (2010)

High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence
por: Meza-Zepeda, Leonardo A, et al.
Publicado: (2008)

Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion
por: Li, Wei, et al.
Publicado: (2010)

FGFR2 is overexpressed in myxoid liposarcoma and inhibition of FGFR signaling impairs tumor growth in vitro
por: Künstlinger, Helen, et al.
Publicado: (2015)

Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
por: Kerboeuf, Mikael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e52rk5oagughrlruo7i59ribnr